Volume Spike Investor

Savient Pharmaceuticals, Inc. (NASDAQ: SVNT) is a stock we are seeing a huge spike in trading of its stock and options ahead of Tuesday’s FDA review of its gout drug: As of 2:30 PM EST we have seen 8.8 million shares trade hands, while the normal trading volume is only 1.85 million shares.  We are also seeing an exponential surge in options trading compared to normal days.  Savient’s stock is up 3.6% at $9.60 and the 52-week trading range is $2.80 to $28.42.  FULL DETAILS are available at BioHealthInvestor.com. -Jon Ogg